Skip to content

M. Ross Bullock, M.D., Ph.D.

Professor, Department of Neurological Surgery
Director, Clinical Neurotrauma

Research Interests

Preclinical Mechanistic and Neuroprotection Research in Traumatic Brain Injury and Clinical trials, and Neuromonitoring Techniques in the Injured Brain

Ross Bullock, M.D, Ph.D.
Ross Bullock, M.D, Ph.D.

Many mechanisms of injury, and strategies for neuroprotection and repair, are common to both Severe Traumatic Brain injury, and Spinal cord injury.Cell replacement therapy, either mediated by neurotrophin augmentation of endogenous Progenitor cells, or transplantation strategies, has become an important lab focus, since the award of an RO1 entitled “Modulation of Hippocampal Neurogenesis and Cognitive recovery after neurotrauma”.This offers the prospect of enhancing recovery, in patients with residual severe neurological deficit, after TBI. New therapies, such as perfluorocarbons offer the prospect of ameliorting the neuronal death that occurs, in TBI, and Strategies for their use will be explored in animal models, and human trials.



M. Ross Bullock, Ph.D.

  • The Miami Project to Cure Paralysis
    1095 NW 14th Terrace (R-48)
    Miami, FL 33136
  • (305) 243-8183
  • (305) 243-3914




National Neurotrauma Society

Chair, Department of Defense Congressionally mandated Advisory Board for Traumatic Brain Injury, 2009.

Olivecrona award for research in Traumatic Brain Injury, 2007 (Karolinska Institute, Stockholm)

Safety monitoring board, Traumatic Brain Injury in Latin America: Lifespan analysis NIH NINDS .

Congress of Neurological Surgeons